Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rainmed MedicalHKSE:02297 50 Market Cap is HK$327.92 Mil as of Jul. 21, 2026. GuruFocus rates HKSE:02297 with a GF Score™ of 50/100 and a GF Value™ of HK$0.08 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 865 Medical Devices & Instruments companies, Rainmed Medical ranks worse than 64.16% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Rainmed Medical's share price for the quarter that ended in Dec. 2025 was HK$0.27. Rainmed Medical's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 1,401.36 Mil. Therefore, Rainmed Medical's market cap for the quarter that ended in Dec. 2025 was HK$378.37 Mil.
Rainmed Medical's quarterly market cap
increased
from Dec. 2024 (HK$199.69 Mil) to Jun. 2025 (HK$280.27 Mil) and
increased
from Jun. 2025 (HK$280.27 Mil) to Dec. 2025 (HK$378.37 Mil).
Rainmed Medical's annual market cap
declined
from Dec. 2023 (HK$502.15 Mil) to Dec. 2024 (HK$199.69 Mil) but then
increased
from Dec. 2024 (HK$199.69 Mil) to Dec. 2025 (HK$378.37 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Rainmed Medical's Enterprise Value for Today is HK$184.61 Mil.
Rainmed Medical (HKSE:02297) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Rainmed Medical Market Cap Related Terms
Rainmed Medical Market Cap Historical Data
* Premium members only.
The historical data trend for Rainmed Medical's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02297 vs ABT, SYK, MDT: Market Cap Comparison
For the Medical Devices subindustry, Rainmed Medical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rainmed Medical Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Rainmed Medical's Market Cap distribution charts can be found below:
* The bar in red indicates where Rainmed Medical's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Rainmed Medical's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rainmed Medical (HKSE:02297) has a Market Cap of HK$327.92 Mil as of Jul. 21, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Rainmed Medical and its competitors. According to the industry distribution chart, Rainmed Medical ranks #555 out of 865 companies in the Medical Devices & Instruments industry, placing it in the top 64.2%.
Is Rainmed Medical's Market Cap too high?
Rainmed Medical's current Market Cap is HK$327.92 Mil. Based on the distribution chart, Rainmed Medical ranks #555 out of 865 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Rainmed Medical has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Rainmed Medical's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Rainmed Medical ranks #555 out of 865 companies for Market Cap. This places Rainmed Medical in the lower half of its industry. The industry median Market Cap is 111.74. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 111.74, based on 865 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Rainmed Medical and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 111.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rainmed Medical's current Market Cap is HK$327.92 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rainmed Medical stock overvalued right now?
Based on GuruFocus' analysis, Rainmed Medical (HKSE:02297) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.08, compared to a current price of HK$0.23 — trading 192.5% above its estimated fair value. The current Market Cap is HK$327.92 Mil. Rainmed Medical's overall GF Score™ is 50/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Rainmed Medical (HKSE:02297), the current Market Cap is HK$327.92 Mil as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rainmed Medical (HKSE:02297) Overvalued in 2026?
Based on GuruFocus' analysis, Rainmed Medical stock appears to be overvalued.
The current stock price of HK$0.23 is trading 192.5% above its estimated GF Value™ of HK$0.08.
GuruFocus considers Rainmed Medical to be Significantly Overvalued.
Key valuation signals for HKSE:02297:
Market Cap: HK$327.92 Mil
GF Value™: HK$0.08 vs. price of HK$0.23 (192.5% above fair value)
No single metric tells the full story. See the HKSE:02297 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rainmed Medical Ltd is focused on the design, development, and commercialization of coronary angiography-derived fractional flow reserve systems and coronary angiography-derived index of microcirculatory resistance systems. The company's core products, the caFFR system and the caIMR system, are medical devices used to evaluate the severity of myocardial ischemia arising from coronary artery stenosis and microvascular dysfunction, which are the underlying causes of coronary artery diseases (CAD). It operates in China and Other countries.
50GF Score
Get the complete analysis for HKSE:02297
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02297 has been successfully added to your 
